<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000045366">
  <TermName>pyrazoloacridine</TermName>
  <TermPronunciation>(PEER-uh-ZOH-loh-A-krih-deen)</TermPronunciation>
  <TermDefinition>
    <DefinitionText>A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called acridines.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000730907" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;pyrazoloacridine&quot;" language="en" id="_3"/>
  <MediaLink ref="CDR0000730906" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;pirazoloacridina&quot;" language="es" id="_4"/>
  <SpanishTermName>pirazoloacridina</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Sustancia en estudio para el tratamiento del c√°ncer. Pertenece al tipo de medicamentos llamados acridinas.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateLastModified>2005-02-15</DateLastModified>
</GlossaryTerm>
